Study guide

9.2 Medication Therapy Review (MTR)

PTCB Medication Therapy Management Certificate Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts & Format 1.2 Eligibility, Application & Testing 1.3 Pharmacy Technician Role in MTM 1.4 Domain Weights & Study Strategy

2 Chapter 2: Medication Product Knowledge

2.1 Strengths, Doses, and Drug Classes 2.2 Dosage Forms, Routes, and Administration Instructions 2.3 Storage, Special Handling, and Duration of Therapy 2.4 Interchangeable Classes and Forms for Cost Savings

3 Chapter 3: Terminology & History Collection

3.1 Patient-Friendly Medical Terminology 3.2 Medication Allergy vs Medication Intolerance 3.3 Adherence Definitions in Medication History 3.4 Medical History Components for MTM

4 Chapter 4: Medication-Related Problems & Labs

4.1 Common Medication-Related Problems Overview 4.2 Side Effects, Adverse Drug Reactions & Allergies in MTM 4.3 Nonadherence, Affordability Barriers & Gaps in Therapy 4.4 Lab Measures & Related Medical Terms in MTM

5 Chapter 5: Adherence Calculations

5.1 Days’ Supply, Quantity, and Dose 5.2 Proportion of Days Covered (PDC) 5.3 PQA Threshold & Star Ratings Adherence Measures

6 Chapter 6: Documentation Accuracy Reviews

6.1 Personal Medication Record (PMR) Accuracy Review 6.2 MAP and CMR Documentation Accuracy 6.3 MTM Billing Fields Accuracy Checks

7 Chapter 7: Prescribing Errors & Therapy Conflicts

7.1 Types of Prescribing Errors 7.2 Inappropriate Prescribing & Duplicate Therapy 7.3 Drug Interactions & Conflicting Therapies 7.4 Impact of Prescribing Errors & Medication Problems

8 Chapter 8: High-Risk Medications in Older Adults

8.1 2023 AGS Beers Criteria: High-Risk Medications in Older Adults 8.2 STOPP/START Concepts & Anticholinergic Burden in MTM Screening 8.3 High-Alert & Narrow Therapeutic Index Awareness for MTM Tech Support

9 Chapter 9: MTM Core Elements

9.1 Purpose of MTM & Five Core Elements 9.2 Medication Therapy Review (MTR) 9.3 Personal Medication Record (PMR) 9.4 Medication-Related Action Plan (MAP)

10 Chapter 10: Intervention, Documentation & CMS Rules

10.1 Intervention, Referral & Follow-Up 10.2 MTM Documentation Standards 10.3 CMS Part D MTM Targeting Requirements

11 Chapter 11: CMR, TMR, Billing & Workflow

11.1 Comprehensive Medication Review (CMR) 11.2 Targeted Medication Review (TMR) 11.3 CPT Billing Codes for MTM (99605 / 99606 / 99607) 11.4 Workflow Prioritization, Stages & Timelines

9.2 Medication Therapy Review (MTR)

Key Takeaways Explain This Topic AI

Medication Therapy Review (MTR) is a systematic process: collect patient-specific information, assess medication therapies, prioritize medication-related problems, and create a plan to resolve them.

Comprehensive MTR evaluates the full regimen and overall medication use; targeted MTR focuses on a specific actual or potential medication-related problem.

Technicians gather prescriptions, OTCs, herbals/supplements, allergies/intolerances, conditions, social history, immunizations, adherence clues, and relevant labs already on file—without making the clinical assessment.

Pharmacists assess indication, effectiveness, safety, and adherence; identify and prioritize MRPs; and determine interventions, referrals, and monitoring.

In Part D and many programs, the interactive Comprehensive Medication Review (CMR) is the comprehensive review encounter; Targeted Medication Reviews (TMRs) address focused issues on a required cadence.

Last updated: August 2026

9.2 Medication Therapy Review (MTR)

Quick Answer: An MTR systematically collects patient information, assesses therapies, builds a prioritized MRP list , and plans resolution. Comprehensive MTR looks at the whole regimen; targeted MTR focuses on a specific problem. Technicians gather and organize; pharmacists assess and decide.

The Medication Therapy Review (MTR) is the first core element and the clinical heart of MTM. Without a real review, the PMR is just a list and the MAP is guesswork. Domain 3 expects you to know what an MTR is, how comprehensive and targeted reviews differ, and where the technician’s work stops and the pharmacist’s assessment begins.

Definition: What an MTR Includes

In the APhA/NACDS model, an MTR is a systematic process of:

  • Collecting patient-specific information
  • Assessing medication therapies to identify medication-related problems
  • Developing a prioritized list of medication-related problems
  • Creating a plan to resolve them

MTRs may be delivered face-to-face, by phone, or by other interactive telehealth methods allowed by the program. The defining feature is interactive clinical review , not a silent chart glance with no patient engagement when a comprehensive review is required.

  • MTR component What “done well” looks like Failure mode
  • Information collection Full regimen + history + adherence context Rx-only list; OTCs ignored
  • Assessment Indication, effectiveness, safety, adherence reviewed No clinical judgment—only data dump
  • Prioritized MRPs Problems ranked by urgency/impact Unordered laundry list with no focus
  • Resolution plan Clear next steps (intervene, refer, monitor, educate) Problems noted but nothing scheduled
  • Comprehensive vs. Targeted MTR
  • Feature Comprehensive MTR Targeted MTR
  • Scope Entire medication regimen and overall medication use Specific actual or potential MRP

Typical trigger Annual CMR-style encounter; new complex patient; major transition of care Alert for nonadherence, interaction, high-risk drug, lab abnormality, recent change

Time / depth Broader interview and reconciliation Focused problem-solving

Outputs Full problem list, updated PMR, MAP items, interventions as needed Focused intervention/documentation; may update PMR/MAP for that issue

Program language Often aligned with Comprehensive Medication Review (CMR) in Part D MTM Often aligned with Targeted Medication Review (TMR) follow-ups

Exam tip: “Comprehensive” does not mean “the technician assesses everything clinically.” It means the review covers the full regimen . “Targeted” does not mean “unimportant”—a targeted review of bleeding risk on anticoagulants can be life-critical.

When each type fits

Comprehensive: patient with multiple chronic diseases and many medications; recent hospital discharge with regimen changes; first MTM enrollment encounter requiring a CMR.

Targeted: PDC drop on a statin; possible duplicate ACE inhibitor + ARB; new potassium result while on spironolactone; patient reports stopping insulin because of cost.

What Technicians Gather (Data Package for the MTR)

Technicians make or break MTR quality by the completeness and organization of the intake package. Collect and organize:

  • Medication history
  • Prescription medications from all pharmacies (including mail order and specialty)
  • Strengths, directions, routes, and how the patient actually takes each drug
  • Start dates / stop dates when known; PRN patterns
  • Samples, borrowed medications, and medications in pill organizers
  • OTCs (pain relievers, antacids, antihistamines, sleep aids)
  • Herbals, vitamins, minerals, and dietary supplements
  • Safety and response history
  • Allergies vs intolerances / side effects (describe the reaction)
  • Past adverse drug reactions
  • Vaccination history when relevant to the encounter
  • Medical and social context
  • Chronic and acute conditions (patient-friendly language is fine in intake notes)
  • Prescribers and care settings (PCP, specialists, recent ED/hospital)

Social history that affects use: alcohol, tobacco, living situation, caregiver support, health literacy barriers, cost concerns, work shifts that disrupt dosing

  • Adherence and access clues
  • Missed doses and reasons (forgetfulness, side effects, cost, confusion)
  • Recent gaps visible in refill history (flag for pharmacist—do not invent clinical conclusions)
  • Barriers: transportation, prior authorizations, formulary issues
  • Objective data already available

Recent vitals or labs on file (A1C, potassium, blood pressure, INR, etc.)—present them; do not interpret beyond your role

  • Hospital discharge medication lists for reconciliation
  • Technician gathering checklist
  • Asked about OTCs/herbals/supplements explicitly
  • Separated allergy from intolerance language when patient describes reactions
  • Noted actual use vs labeled directions when they differ
  • Listed all pharmacies/sources of medication
  • Flagged high-risk discrepancies for pharmacist attention
  • Organized a draft medication list ready for MTR assessment

Trap: “We already have claims data, so skip the interview.” Claims miss OTCs, cash-pay fills elsewhere, samples, and real-world adherence behavior.

What Pharmacists Assess During the MTR

The pharmacist (or other qualified provider) uses the data package to evaluate therapy systematically. A common clinical frame is:

Assessment domain Pharmacist questions

Indication Is there a reason for each medication? Is a condition untreated?

Effectiveness Are goals unmet (e.g., A1C, BP)? Is the dose/regimen inadequate?

Safety Interactions, contraindications, adverse effects, high-risk meds in older adults, renal dosing concerns?

Adherence / access Is the patient able and willing to take therapy as intended? Cost or complexity barriers?

From that assessment, the pharmacist:

  • Identifies medication-related problems
  • Prioritizes them (bleeding risk usually outranks a minor duplicate vitamin)
  • Selects interventions (education, therapy recommendations, monitoring) and/or referrals
  • Determines what belongs on the patient-facing MAP
  • Ensures the PMR reflects the reconciled regimen

Technicians may notice patterns (“two NSAIDs listed”) and flag them. Final MRP identification and prioritization remain clinical.

How MTR Connects to Other Core Elements

Loading diagram... Comprehensive vs Targeted MTR Pathways

  • Realistic MTR Scenarios
  • Scenario A — Comprehensive review after discharge

Mr. Lopez was discharged with new heart-failure medications. The technician reconciles discharge list, community fills, and OTC ibuprofen the patient still takes for knee pain. The pharmacist’s comprehensive MTR prioritizes NSAID risk with heart failure and diuretics, updates the PMR, places “stop ibuprofen; use acetaminophen as directed” style actions on the MAP after clinical counseling, and documents prescriber communication.

Scenario B — Targeted adherence review

A queue alert shows Ms. Chen’s statin PDC below goal. The technician confirms the patient stopped the drug after muscle aches and never told the clinic. The pharmacist performs a targeted MTR on statin intolerance, considers alternatives/monitoring, and documents follow-up—without needing a full annual CMR that day (program rules permitting).

Scenario C — Role boundary

A technician sees two anticoagulants on the draft list. Correct action: flag and escalate before the review finishes. Incorrect action: tell the patient to stop one anticoagulant during intake.

Scenario D — Incomplete collection sinks the MTR

Intake lists only profile Rx drugs. Mid-review the patient mentions St. John’s wort. The MTR must pause to update the medication history—proving why technician probing for supplements is part of MTR quality.

CMR/TMR Language vs. MTR Language

For exam and workplace fluency:

MTR = core-element name for the review process (comprehensive or targeted).

CMR = program term (especially Medicare Part D) for an interactive comprehensive review with a written summary.

TMR = program term for ongoing targeted reviews addressing specific problems or monitoring needs.

Think: CMR/TMR are how many plans operationalize comprehensive and targeted MTRs. Later chapters detail CMR written summaries, quarterly TMR expectations, and billing timelines. Here, master the review logic and your support role.

Quick self-check

Can you define MTR in one sentence without using only the letters?

Can you contrast comprehensive vs targeted with one example each?

Can you list five history elements technicians must gather?

Can you name four domains pharmacists assess?

If yes, you are ready for PMR and MAP deep dives that turn MTR findings into patient tools.